Dr. Fishbein received his undergraduate and medical degrees from the University of Illinois. He completed a residency in anatomic and clinical pathology at Harbor General Hospital/UCLA Medical Center. He is board certified in anatomic and clinical pathology.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Cost is one reason why more heart transplants aren't done. The cost is always
at least a few hundred thousand dollars. Not all insurers will pay for heart
transplant. The longer the recipient lives, the more expensive the
transplant. Of course, if the heart lasts longer, the benefit is also
greater to the patient and to society. It's also not easy to qualify for a heart
transplant. One has to have a very bad heart but an otherwise healthy body.
However, the major limiting factor is the availability of donor hearts. For many
reasons, individuals and families refuse to donate organs that could be
life-saving to others. Sometimes, even when an organ is available, there is no
good match. Other times, there is no way to get the heart to a suitable
recipient in time for the organ to still be viable.
What is the future of heart transplant?
There are several ways to help patients with end-stage heart disease. One is
to get more donors for heart transplant. This will require teaching people
the benefits of transplantation in hope of changing society's attitudes. Better
methods of preserving organs and preventing and treating rejection are
constantly being developed. In the end, however, there will never be enough
donor hearts. Indeed, artificial hearts already exist but have a limited life-span. Patients with artificial hearts are at high risk of developing
infection and blood clots related to the device. Better devices are being
developed all the time. What about the use of animal organs, also called
xenotransplantation? These organs are too "foreign" and thus the problems with
rejection are currently insurmountable.
Congestive heart failure (CHF) is a condition in which the heart's function as a pump is inadequate to meet the body's needs. A poor blood supply resulting from congestive heart failure may cause the body's organ systems to fail, leading to a weakened heart muscle and fluid accumulation in the lungs and body tissue. There are many diseases that can impair pumping efficiency and symptoms of congestive heart failure including fatigue, diminished exercise capacity, shortness of breath, and swelling. Treatments include lifestyle modifications, medications, heart transplant, and therapy.
Vancomycin-resistant enterococci (VRE) infection is the most common type of infection acquired by patients while hospitalized. Patients at risk for VRE are those who are already ill, and hospitalized, including individuals with diabetes, elderly, ICU patients, kidney failure patients, or patients requiring catheters. Enterococci can survive for months in the digestive tract and female genital tract. Other risk factors for acquiring VRE include those how have been previously treated with vancomycin and combinations of other antibiotics. Treatment of VRE is generally with other antibiotics other than vancomycin. Prevention of VRE can be achieved by proper hand hygiene.
Medical shock is a life-threatening medical condition. There are several types of medical shock, septic shock, anaphylactic shock, cardiogenic shock, hypovolemic shock, and neurogenic shock. Causes of shock include heart attack, heart failure, heavy bleeding (internal and external), infection, anaphylaxis, spinal cord injury, severe burns, chronic vomiting or diarrhea. Low blood pressure is the key sign of sock. Treatment is dependant upon the type of shock.
Heart failure is caused by many conditions including coronary artery disease, heart attack, cardiomyopathy, and conditions that overwork the heart. Symptoms of heart failure include congested lungs, fluid and water retention, dizziness, fatigue and weakness, and rapid or irregular heartbeats.
Dilated Cardiomyopathy is a condition where the heart's ability to pump blood is decreased because the heart's main pumping chamber is enlarged and weakened. Symptoms of dilated cardiomyopathy include chest pain, heart failure, swelling of the lower extremities, fatigue, weight gain, fainting, palpitations, dizziness and blood clots.
The heart is a very important organ in the body. It is responsible for continuously pumping oxygen and nutrient-rich blood throughout your body to sustain life. It is a fist-sized muscle that beats (expands and contracts) 100,000 times per day, pumping a total of five or six quarts of blood each minute, or about 2,000 gallons per day.